Utilization of agents to prevent skeletal-related events among patients with multiple myeloma: analysis of real-world data

ConclusionsThese results highlight the possibility of suboptimal prevention of skeletal-related events due to non-compliant dosing and non-persistence after patients initiate BTA therapy.

Source: Supportive Care in Cancer - January 25, 2018 Category: Cancer & Oncology Source Type: research